Curevo Vaccine

Updated: March 08, 2026
CEO - George Simeon
CEO - George Simeon
Country: USA | Funding: $196M (+)
Founded: 2018

Website: https://curevovaccine.com/

Curevo is a clinical-stage biotechnology company developing next-generation, non-mRNA vaccines for infectious diseases.

Competitors